Market Tracker

08/28 6:01pm ET

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.395
Delayed Data
As of Aug 28
 +0.005 / +1.28%
Today’s Change
0.34
Today|||52-Week Range
3.98
-75.31%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close0.39
Today’s open0.39
Day’s range0.39 - 0.42
Volume775,353
Average volume (3 months)1,577,494
Market cap$25.7M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+72.57%
Earnings growth (this year)+72.78%
Earnings growth (next 5 years)--
Revenue growth (last year)-82.21%
P/E ratioNM
Price/Sales368.74
Price/Book7.44

Competitors

 Today’s
change
Today’s
% change
GENEGenetic Technologies...+0.16+7.48%
RGBPRegen BioPharma Inc-0.00-2.13%
ENUMEnumeral Biomedical ...+0.01+1.74%
--Cell Source Inc0.000.00%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 12, 2015
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$71.0K
Annual profit (last year)-$8.8M
Net profit margin-12,394.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Westborough, Massachusetts

Forecasts